Revance Therapeutics Inc - Wutah dodolan YoY sajrone rolas wulan kepungkur RVNC

Tandha merek Revance Therapeutics Inc (RVNC)

The investment potential of Revance Therapeutics (RVNC) is based on outsourcing production and logistics to external partners. Year-over-year revenue dynamics over the last 12 months confirm this trend, with the indicator value standing at 97.00. Growth is driven by physician loyalty to the long-acting Daxxify and the implementation of robotic filling lines with AI-driven purity control, ensuring high product quality.

RVNC Revance Therapeutics Inc: Wutah dodolan YoY sajrone rolas wulan kepungkur ing interval 11.02.2024 - 20.02.2024

Revance Therapeutics Inc (RVNC) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
Pambiji fundamental perusahaan:Revance Therapeutics
Produk seri Revance Therapeutics, Inc

This indicator measures the percentage change in revenue over the last 12 months relative to the same period last year, allowing investors to filter out short-term noise and assess the true pace of business expansion. By analyzing the rolling 12-month sales growth rate year-over-year, one can track the impact of Daxxify filling line robotization and the implementation of AI control on the real scalability of operating revenues at Revance Therapeutics (RVNC).